Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Ovarian Cancer
Interventions: BIOLOGICAL: HER-2/neu peptide vaccine|BIOLOGICAL: sargramostim
Sponsor: University of Washington